Inhibition of GOT1 could regulate NADPH synthesis and then regulated ROS levels to counteract oxidative stress, which making colorectal cancer cells sensitive to 5-fluorouracil (12) and breast cancer cells sensitive to doxorubicin (15), enhancing anti-cancer effects. Here, GOT1 is linked to breast cancer.